Tashkin D P, Khalsa M E, Gorelick D, Chang P, Simmons M S, Coulson A H, Gong H
Department of Medicine, University of California, School of Medicine, Los Angeles 90024-1690.
Am Rev Respir Dis. 1992 Jan;145(1):92-100. doi: 10.1164/ajrccm/145.1.92.
We determined the prevalence of respiratory symptoms and lung dysfunction in a large sample of habitual smokers of freebase cocaine ("crack") alone and in combination with tobacco and/or marijuana. In addition, we compared these findings with those in an age- and race-matched sample of nonusers of crack who did or did not smoke tobacco and/or marijuana. A detailed respiratory and drug use questionnaire and a battery of lung function tests were administered to (1) a convenience sample of 202 habitual smokers of cocaine (cases) who denied intravenous drug abuse and (2) a reference sample of 99 nonusers of cocaine (control subjects). The cocaine smokers (85% black) included the following: 68 never-smokers of marijuana, of whom 43 currently smoked tobacco and 25 did not, and 134 ever-smokers of marijuana (42 current and 92 former), of whom 92 currently smoked tobacco and 42 did not. The control subjects (96% black) included the following: 69 never-smokers of marijuana, of whom 26 currently smoked tobacco and 43 did not, and 30 ever-smokers of marijuana (18 current and 12 former), of whom 21 currently smoked tobacco and 9 did not. Cases smoked an average of 6.5 g cocaine per week for a mean of 53 months. The median time of the most recent use of crack prior to study was 19 days (range less than 1 to 180 days). After controlling for the use of other smoked substances, frequent crack use was associated with: (1) a high prevalence of at least occasional occurrences of acute cardiorespiratory symptoms within 1 to 12 h after smoking cocaine (cough productive of black sputum [43.7%], hemoptysis [5.7%], chest pain [38.5%], usually worse with deep breathing, and cardiac palpitations [52.6%]) and (2) a mild but significant impairment in the diffusing capacity of the lung.(ABSTRACT TRUNCATED AT 250 WORDS)
我们确定了仅吸食游离碱可卡因(“快克”)以及同时吸食烟草和/或大麻的大量习惯性吸食者的呼吸道症状患病率和肺功能障碍情况。此外,我们将这些结果与年龄和种族匹配的未吸食快克但吸食或未吸食烟草和/或大麻的样本进行了比较。对(1)202名否认静脉吸毒的可卡因习惯性吸食者(病例组)的便利样本以及(2)99名未吸食可卡因者(对照组)的参考样本进行了详细的呼吸道和药物使用问卷调查以及一系列肺功能测试。可卡因吸食者(85%为黑人)包括:68名从未吸食过大麻者,其中43名目前吸食烟草,25名不吸食;134名曾经吸食过大麻者(42名目前吸食,92名曾经吸食),其中92名目前吸食烟草,42名不吸食。对照组(96%为黑人)包括:69名从未吸食过大麻者,其中26名目前吸食烟草,43名不吸食;30名曾经吸食过大麻者(18名目前吸食,12名曾经吸食),其中21名目前吸食烟草,9名不吸食。病例组平均每周吸食6.5克可卡因,平均时长为53个月。研究前最近一次使用快克的中位时间为19天(范围为不到1天至180天)。在控制了其他吸入性物质的使用后,频繁吸食快克与以下情况相关:(1)吸食可卡因后1至12小时内至少偶尔出现急性心肺症状的患病率较高(咳出黑色痰液[43.7%]、咯血[5.7%]、胸痛[38.5%],通常深呼吸时加重,以及心悸[52.6%]);(2)肺弥散功能有轻度但显著的损害。(摘要截断于250字)